Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach.
Randomized Controlled Trial of Advance Notification Phone Calls vs Text Messages Prior to Mailed Fecal Test Outreach.
复制标题
DOI:
10.1016/j.cgh.2020.07.053
复制
发表时间:
2021-11
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Mailing fecal immunochemical test (FITs) to individuals who are due for screening (mailed FIT outreach) increases colorectal cancer (CRC) screening. Little is known about how phone-based advance notifications (primers) affect the effectiveness of mailed FIT outreach programs. We performed a prospective study of patients at a large urban health center, 50–75 years old and due for screening, with no record of a prior FIT. Participants were randomly assigned to groups that received a live phone call primer (n = 1203) or a text message primer (n = 1622), from June through December 2018. The participants were then mailed a FIT kit, followed by 2 automated calls, and live reminder calls delivered by the care team. The main outcome was completion of FIT within 3 months of assignment to the live phone call or text message group. Participants had a FIT completion rate of 16.8%, a mean age of 58 years, and 80% were Latino. In adjusted intention to treat analyses (n = 2825), FIT completion rates were higher in the patients assigned to receive a live phone call vs text message primer (percentage point difference, 3.3%; 95% CI, 0.4%–6.2%). Between-group differences increased to 7.3% points (95% CI, 3.6%–11.0%) in the per-protocol analysis of 2144 participants reached by the text message (1320/1622, 81%), live call (438/1203, 36%), or voice message (386/1203, 32%). This rate increased to 14.9% points (95% CI; 9.6%–20.1%) in the per-protocol analysis of 1758 participants reached by the text message or reached by the live call. In a randomized trial, advance notification live phone calls outperformed text messages in prompting health center patients who had not previously completed a FIT to complete a mailed FIT. Clinicaltrials.gov no: NCT03167125
登录
查看更多内容
影响因子:
2.8
作者:
Nielson CM;Rivelli JS;Fuoco MJ;Gawlik VR;Jimenez R;Petrik AF;Coronado GD
通讯作者:
Coronado GD
DOI:
10.1097/meg.0000000000000314
发表时间:
2015-05-01
影响因子:
2.1
作者:
Santare, Daiga;Kojalo, Ilona;Leja, Marcis
通讯作者:
Leja, Marcis
影响因子:
10.3
作者:
Somsouk, Ma;Rachocki, Carly;Ladabaum, Uri
通讯作者:
Ladabaum, Uri
影响因子:
5.1
作者:
van Roan, A. H. C.;Hal, L.;Kuipers, Ernst J.
通讯作者:
Kuipers, Ernst J.
影响因子:
5.7
作者:
Goldman, Shira N.;Liss, David T.;Baker, David W.
通讯作者:
Baker, David W.